Ed Miner, MD, FACC Utah, Chapter President ACC Governor, Utah |
Join your colleagues from Idaho, Nevada, New Mexico, Utah, and Wyoming on September 6th and 7th for a weekend of hot topics in cardiovascular care including heart failure, amyloid, prevention, clinician wellness, atrial fibrillation, and more! CME/CNE/MOC credits will be provided. We look forward to a wonderful weekend of networking and learning together at the Park City, Utah.
For more information and to register, please visit: ACC Rockies Chapter Meeting 2024
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Clinical and Imaging Diagnostic Criteria for MyocarditisWhat is the comparative predictive value of ESC criteria for clinically suspected myocarditis, updated Lake-Louise criteria (LLC), AHA criteria for probable acute myocarditis (pAM), and expert consensus criteria for acute myocarditis (AM) and complicated myocarditis (CM)?
- CV Events Following COVID-19 VaccinationWhat are the risks of several cardiovascular (CV) and cerebrovascular events following coronavirus disease 2019 (COVID-19) vaccination in a Swedish nationwide register-based cohort?
- Breast Cancer and CV Health: Key PointsThe following are key points to remember from a review about breast cancer and cardiovascular (CV) health.
- ACC Practice Made Perfect: Building Blocks: Strategies for Cardiovascular Service Line DevelopmentWelcome to the Cardiovascular (CV) Dyad Leadership Strategic Planning Series! In episode one of four, Dr. Jeff Carstens discusses with Drs. Tom Draper and Michael Montgomery steps to developing a strategic plan for the CV service line.
- Tirzepatide for the Treatment of Obstructive Sleep Apnea and ObesityThe goal of the SURMOUNT-OSA trial was to determine the effect of tirzepatide, both alone and in the setting of positive airway pressure (PAP) therapy, on obstructive sleep apnea (OSA) burden in patients with obesity.